Justification for a new cohort study of people aging with and without HIV infection

Journal of Clinical Epidemiology

Volumn 54, Issue 12 SUPPL. 1, 2001, Pages

  Justice, A C ^a,b   Landefeld, C S ^a   Asch, S M ^c   Gifford, A L ^d   Whalen, C C ^e   Covinsky, K E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cohort study; HIV negative; HIV positive; People aging

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; MEDICAL RECORD; MORTALITY; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RISK;

AGING; CHRONIC DISEASE; COMORBIDITY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; LONGITUDINAL STUDIES; RESEARCH DESIGN; UNITED STATES; VETERANS;

EID: 0035668496     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00440-1     Document Type: Conference Paper

References (73)

1. Aging in AIDS; AIDS and aging
2. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antitretroviral therapy; a collaborate re-analysis
3. The survival experience of older and younger adults with AIDS; is there a growing gap in survival?
4. The role of functional status in predicting inpatient mortality with AIDS
5. A new prognostic staging system for the acquired immunodeficiency syndrome
6. Frequencies of opportunistic diseases prior to death among HIV-infected persons
7. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study; 1985-1991
8. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997
9. Liver fibrosis progression in Human Immunodeficiency Virus and Hepatitis C virus coinfected patients
10. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) cohort study (HAVACS); the effects of coinfection on survival
11. Diagnosis, prediction, and natural course of HIV-1 protese-inhibitor-associated lipodystrophy, hyperlipiddaemia, and diabetes mellitus; a cohort study
12. Adverse events from drug therapy for human immunodeficiency virus disease
13. Drugs for HIV infection
14. Hit HIV-1 hard, but only when necessary
15. Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir
16. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
17. Neuropsychiatric aspects of HIV-infection among older adults
18. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1 associated morbidity and mortality
19. General medical and psychiatric comorbidity among HIV infected veterans in the post-HAART era
20. Veterans Aging Cohort 3 Site Study (VACS 3)
21. Costs of medical injuries in Utah and Colorado
22. Incidence of adverse events and negligence in hospitalized patients; results of the Harvard Medical Practice Study I
23. Preventable medical injuries in older patients
24. How should clinical care of the aged differ?
25. A comparison of observational studies and randomized, controlled trials
26. Randomized, controlled trials, observational studies, and the hierarchy of research designs
27. Randomized clinical trials; the worst kind of epidemiology?
28. When to base clinical policies on observational versus randomized trial data
29. Observational studies as alternatives to randomized clinical trials in surgical clinical research
30. Problems in the conduct and analysis of randomized clinical trials; are we getting the right answers to the wrong questions?
31. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery
32. Evolution of the cohort study
33. Perspective; Cohort studies
34. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
35. Use of computerized record linkage in cohort studies
36. Linking automated databases for research in managed care
37. Health-related quality of life in persons with Acquiered Immune Deficiency Syndrome
38. Measuring health-related quality of life
39. Measuring health status; what are the necessary measurement properties?
40. The clinical importance of provider-reported HIV symptoms compared to patient-report
41. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms; a comparison with self-reported symptoms
42. Symptoms and science. The frontiers of primary care research
43. HIV care providers do not appreciate the full range of their patients' symptoms
44. Screening with the alcohol use disorders identification test (AUDIT) in an inner-city population
45. Adherence; a necessity for sucessful HIV combination therapy
46. Measuring adherence in AIDS Clinical Trials Group antiretroviral trials
47. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials; the AACTG Adherence Instruments
48. AIDS among the homeless of Boston; a cohort study
49. Measuring attributes of primary care; development of a new instrument
50. Primary care instrument
51. The association of attributes of primary care with the delivery of clincial preventive services
52. The impact of insurance type and forced discontinuity on the delivery of primary care
53. The value of a family physician
54. Assessing illness severity; does clinical judgement work?
55. Resuscitation; how do we decide? A prospective study of physicians' preferences and the clinical course of hospitalized patients
56. The SUPPORT prognostic model
57. How well can physicians estimate mortality in a medical intensive care unit?
58. Clinical assessments as predictors of one year survival after hospitalization; implications for prognostic stratification
59. The importance of co-existent disease in the occurence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement
60. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
61. Chronic disease as a barrier to breast and cervical cancer screening
62. The treatment of unrelated disorders in patients with chronic medical diseases
63. The importance of comorbidity in HIV-infected patients over 55; a retrospective case-control study
64. Multimorbidity in general practice; prevalence, incidence, and determinants of co-occuring chronic and recurrent diseases
65. Estimating treatment benefits for the elderly; the effect of competing risks
66. Promoting patient safety by preventing medical error